Structures by: Diaz P.
Total: 12
C22H25N3O3
C22H25N3O3
Journal of medicinal chemistry (2009) 52, 2 433-444
a=8.3877(2)Å b=8.4043(2)Å c=15.1821(4)Å
α=100.3570(10)° β=103.5370(10)° γ=101.3700(10)°
C21H23N3O2
C21H23N3O2
Journal of medicinal chemistry (2008) 51, 16 4932-4947
a=7.9246(4)Å b=8.7859(8)Å c=28.0323(12)Å
α=87.074(1)° β=85.771(1)° γ=73.203(1)°
C13H14N4O
C13H14N4O
Dalton transactions (Cambridge, England : 2003) (2007) 32 3516-3525
a=16.291(2)Å b=16.300(2)Å c=9.1949(12)Å
α=90.00° β=90.00° γ=90.00°
C13H16N4O2
C13H16N4O2
Dalton transactions (Cambridge, England : 2003) (2007) 32 3516-3525
a=10.5821(18)Å b=13.149(3)Å c=4.5942(8)Å
α=90.00° β=90.00° γ=90.00°
C88H90F12N8O15.25P4Pd2S4
C88H90F12N8O15.25P4Pd2S4
Dalton transactions (Cambridge, England : 2003) (2007) 32 3516-3525
a=18.6063(11)Å b=21.5364(13)Å c=27.1103(16)Å
α=90.00° β=90.00° γ=90.00°
C99H86Cl2F12Fe2N8O17P4Pd2S4
C99H86Cl2F12Fe2N8O17P4Pd2S4
Dalton transactions (Cambridge, England : 2003) (2007) 32 3516-3525
a=15.828(3)Å b=16.901(3)Å c=20.704(4)Å
α=71.936(4)° β=86.141(4)° γ=87.923(4)°
C100.25H94.5F12N8O18.75P4Pd2S4
C100.25H94.5F12N8O18.75P4Pd2S4
Dalton transactions (Cambridge, England : 2003) (2007) 32 3516-3525
a=15.8443(7)Å b=18.8383(9)Å c=20.6983(8)Å
α=95.680(2)° β=94.482(2)° γ=104.570(2)°
C26H48.17ClCuN8O13.92
C26H48.17ClCuN8O13.92
Inorganic Chemistry (2006)
a=9.1072(2)Å b=23.9835(7)Å c=18.0800(5)Å
α=90.00° β=97.563(2)° γ=90.00°
C17H20CuN4O5
C17H20CuN4O5
Inorganic Chemistry (2006)
a=9.2047(5)Å b=18.3674(10)Å c=10.8366(7)Å
α=90.00° β=93.798(5)° γ=90.00°
C26H36CuN8O10S
C26H36CuN8O10S
Inorganic Chemistry (2006)
a=13.6925(7)Å b=47.613(2)Å c=14.3110(9)Å
α=90.00° β=105.693(5)° γ=90.00°
C26H42Cl2CuN8O9
C26H42Cl2CuN8O9
Inorganic Chemistry (2006)
a=11.0549(6)Å b=21.4021(9)Å c=15.4420(10)Å
α=90.00° β=105.118(5)° γ=90.00°
C32H88Cl4N32Ni4O8Pt2S8
C32H88Cl4N32Ni4O8Pt2S8
Inorganic Chemistry (2004) 43, 7597-7604
a=21.308(5)Å b=17.396(3)Å c=23.274(11)Å
α=90.00° β=97.47(2)° γ=90.00°